39.37

1.86% 0.72

After Hours: 39.37

Xenon Pharmaceuticals Inc (XENE)

Overview News Price History Option Chain Financials Discussions Forecast

Xenon Pharmaceuticals Inc stock is traded at $39.37, with a volume of 381.82K. It is up +1.86% in the last 24 hours and down -2.40% over the past month. Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

Previous Close:

$38.65

Open:

$38.69

24h Volume:

381.82K

Relative Volume:

1.02

Market Cap:

$2.98B

Revenue:

$13.17M

Net Income/Loss:

$-199.06M

P/E Ratio:

-15.81

EPS:

-2.49

Net Cash Flow:

$-156.53M

1W Performance:

-0.71%

1M Performance:

-2.40%

6M Performance:

-8.55%

1Y Performance:

+15.25%

1-Day Range:

$38.13

$39.47

1-Week Range:

$37.66

$40.04

52-Week Range:

$27.98

$50.99

Xenon Pharmaceuticals Inc Stock (XENE) Company Profile

Name

Xenon Pharmaceuticals Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

(604) 484-3300

Address

200 - 3650 GILMORE WAY, BURNABY

Employee

259

Twitter

Next Earnings Date

2024-08-08

Latest SEC Filings

XENE's Discussions on Twitter

Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-04-24	Initiated	Citigroup	Buy
Dec-08-23	Initiated	Robert W. Baird	Outperform
Oct-24-23	Resumed	Cantor Fitzgerald	Overweight
Apr-25-23	Initiated	Cantor Fitzgerald	Overweight
Dec-14-22	Initiated	Goldman	Buy
Dec-12-22	Initiated	Cowen	Outperform
Nov-28-22	Initiated	Wells Fargo	Overweight
Oct-19-22	Initiated	Raymond James	Outperform
Aug-29-22	Initiated	BofA Securities	Buy
Jul-21-22	Initiated	JP Morgan	Overweight
Oct-28-21	Initiated	RBC Capital Mkts	Outperform
Oct-02-20	Initiated	SVB Leerink	Outperform
Jul-21-20	Initiated	Needham	Buy
Jun-01-20	Resumed	Jefferies	Buy
Mar-25-20	Initiated	Wedbush	Outperform
Jan-08-20	Initiated	William Blair	Outperform
Sep-20-19	Initiated	Guggenheim	Buy
Aug-08-18	Reiterated	Stifel	Buy
Mar-13-17	Initiated	Jefferies	Buy
Oct-21-16	Initiated	Stifel	Buy
Sep-26-16	Initiated	Guggenheim	Buy
Apr-14-16	Reiterated	Jefferies	Buy
Oct-30-15	Resumed	Jefferies	Buy
Dec-02-14	Initiated	Canaccord Genuity	Buy

View All

Xenon Pharmaceuticals Inc Stock (XENE) Latest News

03:38 AM

Renaissance Technologies LLC Buys 36,500 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

03:38 AM

Sep 28, 2024

Driehaus Capital Management LLC Increases Stock Holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Sep 28, 2024

Sep 26, 2024

Marshall Wace LLP Cuts Stock Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Sep 26, 2024

Sep 25, 2024

Kenvue Inc. (NYSE:KVUE) Stake Decreased by Pacer Advisors Inc. - Defense World

Sep 25, 2024

Pacer Advisors Inc. Sells 28 Shares of TopBuild Corp. (NYSE:BLD) - Defense World

Sep 25, 2024

Pacer Advisors Inc. Sells 20,524 Shares of PPL Co. (NYSE:PPL) - Defense World

Sep 25, 2024

Pacer Advisors Inc. Has $3.60 Million Position in AutoZone, Inc. (NYSE:AZO) - Defense World

Sep 25, 2024

Pacer Advisors Inc. Buys 1,185 Shares of Comfort Systems USA, Inc. (NYSE:FIX) - Defense World

Sep 25, 2024

PDD Holdings Inc. (NASDAQ:PDD) Position Increased by Pacer Advisors Inc. - Defense World

Sep 25, 2024

Pacer Advisors Inc. Sells 27,232 Shares of NVR, Inc. (NYSE:NVR) - Defense World

Sep 25, 2024

Mount Yale Investment Advisors LLC Sells 683 Shares of BellRing Brands, Inc. (NYSE:BRBR) - Defense World

Sep 25, 2024

Affinity Asset Advisors LLC Acquires 156,840 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Sep 25, 2024

Pacer Advisors Inc. Has $4.44 Million Stock Holdings in Manhattan Associates, Inc. (NASDAQ:MANH) - Defense World

Sep 25, 2024

Pacer Advisors Inc. Raises Holdings in Welltower Inc. (NYSE:WELL) - Defense World

Sep 25, 2024

Pacer Advisors Inc. Sells 5,947 Shares of Aon plc (NYSE:AON) - Defense World

Sep 25, 2024

Peritus High Yield ETF (NYSEARCA:HYLD) Stock Crosses Below 200-Day Moving Average of $25.49 - Defense World

Sep 25, 2024

Sep 24, 2024

Logos Global Management LP Takes Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Sep 24, 2024

First Light Asset Management LLC Sells 13,912 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Sep 24, 2024

First Light Asset Management LLC Lowers Holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Sep 24, 2024

Sep 23, 2024

Ally Bridge Group NY LLC Trims Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Sep 23, 2024

Tri Locum Partners LP Trims Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Sep 23, 2024

(XENE) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Sep 23, 2024

Sep 20, 2024

BioXcel Therapeutics (NASDAQ:BTAI) & Xenon Pharmaceuticals (NASDAQ:XENE) Head to Head Review - Defense World

Sep 20, 2024

Sep 19, 2024

Xenon Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:XENE) - MarketBeat

Sep 19, 2024

Sep 18, 2024

Prepare Yourself for Liftoff: Xenon Pharmaceuticals Inc (XENE) - SETE News

Sep 18, 2024

Bank of New York Mellon Corp Sells 15,656 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Sep 18, 2024

Sep 16, 2024

Arizona State Retirement System Buys 688 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Sep 16, 2024

Sep 14, 2024

Insiders At Xenon Pharmaceuticals Sold US$1.6m In Stock, Alluding To Potential Weakness - Simply Wall St

Sep 14, 2024

Sep 13, 2024

Brokerages Set Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Price Target at $58.78 - MarketBeat

Sep 13, 2024